Koers Bellicum Pharmaceuticals, Inc. OTC Markets
Aandelen
BLCM
US0794814048
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 6,2 mln. 5,82 mln. | Omzet 2022 | 1,5 mln. 1,41 mln. | Marktkapitalisatie | 822K 772K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -8,45 mln. | Nettowinst (verlies) 2022 | -25 mln. -23,46 mln. | EV/omzet 2021 * | - |
Nettoliquiditeiten 2021 * | - 0 | Nettoliquiditeiten 2022 * | - 0 | EV/omzet 2022 * | - |
K/w-verhouding 2021 * |
-
| K/w-verhouding 2022 * |
-
| Werknemers | 13 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 * |
-
| Vrij verhandelbaar | 98,45% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-9,21% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |